Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines. (LONG-SET)

NCT04736745 PHASE1 TERMINATED

The purpose of the protocol, is to assess the safety and efficacy profile of IPN59011 compared to a placebo. IPN59011 is expected to work longer than product already marketed in the treatment of subjects with moderate to severe facial wrinkles.

Details

Lead sponsor	Ipsen
Phase	PHASE1
Status	TERMINATED
Enrolment	56
Start date	Wed Feb 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Oct 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Moderate Upper Facial Lines
• Severe Upper Facial Lines

Interventions

• IPN59011
• Azzalure
• Placebo

Countries

Germany